Literature DB >> 1848599

Investigation of herpes simplex virus type 1 (HSV-1) gene expression and DNA synthesis during the establishment of latent infection by an HSV-1 mutant, in1814, that does not replicate in mouse trigeminal ganglia.

T Valyi-Nagy1, S L Deshmane, J G Spivack, I Steiner, C I Ace, C M Preston, N W Fraser.   

Abstract

In previous studies, the herpes simplex virus type 1 (HSV-1) mutant, in1814, which lacks the trans-inducing function of Vmw65, did not replicate in the trigeminal ganglia of mice following corneal inoculation but did establish a reactivatable latent infection in the ganglia 12 to 24 h after ocular infection. Since in1814 did not replicate in vivo, the molecular events during the establishment phase of latent HSV-1 infection could be characterized without the complications of concurrent productive viral infection. In comparison to parental HSV-1 strain 17+, the expression of viral immediate early (IE), early and late genes and the levels of viral DNA in the trigeminal ganglia of mice following in1814 infection were greatly reduced. However, accumulation of latency-associated transcripts, a prominent feature of latent HSV-1 infection, occurred in a wild-type fashion. Furthermore, low levels of viral gene expression and an increase in the level of viral DNA in the in1814-infected ganglia were not detected until 1 to 2 days after the establishment of HSV-1 latency. Thus, IE gene expression and replication of viral DNA in the trigeminal ganglia are not prerequisites for the establishment of HSV-1 latency. These results suggest that the pathways leading to productive and latent infections in neurons may diverge at an early stage of the host-HSV-1 interaction and that the level of viral IE gene expression has a key role in determining the outcome of infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848599     DOI: 10.1099/0022-1317-72-3-641

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  VP16 serine 375 is a critical determinant of herpes simplex virus exit from latency in vivo.

Authors:  Nancy M Sawtell; Steven J Triezenberg; Richard L Thompson
Journal:  J Neurovirol       Date:  2011-12-06       Impact factor: 2.643

2.  Herpes simplex virus type 1 origins of DNA replication play no role in the regulation of flanking promoters.

Authors:  Bretton C Summers; David A Leib
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

3.  Immunohistochemical analysis of primary sensory neurons latently infected with herpes simplex virus type 1.

Authors:  L Yang; C C Voytek; T P Margolis
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 4.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

5.  The POU-domain factor Brn-3.0 recognizes characteristic sites in the herpes simplex virus genome.

Authors:  E E Turner; J M Rhee; L T Feldman
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

6.  A novel 50-kilodalton fragment of host cell factor 1 (C1) in G(0) cells.

Authors:  R B Scarr; M R Smith; M Beddall; P A Sharp
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

7.  Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis.

Authors:  L I Strelow; D A Leib
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Neuron-specific restriction of a herpes simplex virus recombinant maps to the UL5 gene.

Authors:  D C Bloom; J G Stevens
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo.

Authors:  Xibing Che; Leigh Zerboni; Marvin H Sommer; Ann M Arvin
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

10.  Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice.

Authors:  T Valyi-Nagy; S L Deshmane; B Raengsakulrach; M Nicosia; R M Gesser; M Wysocka; A Dillner; N W Fraser
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.